In last trading session, Relay Therapeutics Inc (NASDAQ:RLAY) saw 1.46 million shares changing hands with its beta currently measuring 1.68. Company’s recent per share price level of $6.66 trading at $0.14 or 2.15% at ring of the bell on the day assigns it a market valuation of $881.38M. That closing price of RLAY’s stock is at a discount of -100.0% from its 52-week high price of $13.32 and is indicating a premium of 14.41% from its 52-week low price of $5.70. Taking a look at company’s average trading volume volume of 1.22 million if we extend that period to 3-months.
Relay Therapeutics Inc (NASDAQ:RLAY) trade information
Upright in the green during last session for gaining 2.15%, in the last five days RLAY remained trading in the green while hitting it’s week-highest on Wednesday, 05/01/24 when the stock touched $6.66 price level, adding 4.45% to its value on the day. Relay Therapeutics Inc’s shares saw a change of -39.51% in year-to-date performance and have moved 4.88% in past 5-day. Relay Therapeutics Inc (NASDAQ:RLAY) showed a performance of -12.37% in past 30-days.
Relay Therapeutics Inc (RLAY) estimates and forecasts
Statistics highlight that Relay Therapeutics Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company added 6.90% of value to its shares in past 6 months, showing an annual growth rate of -1.79% while that of industry is 11.40. Apart from that, the company came lowering its revenue forecast for fiscal year 2024. The company is estimating its revenue growth to increase by 9.00% in the current quarter and calculating 8.60% increase in the next quarter. This year revenue growth is estimated to fall -99.10% from the last financial year’s standing.
8 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $90k for the same. And 8 analysts are in estimates of company making revenue of $70k in the next quarter that will end on Jun 2024. Company posted $226k and $750k of sales in current and next quarters respectively a year earlier. Analysts are expecting this quarter sales to shrink by -60.20% while estimating it to be -90.70% for the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -38.74% during past 5 years.
RLAY Dividends
Relay Therapeutics Inc is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
